In a clinical setting, high levels of IL-6 following PDT of cholangiocarcinomas correlated positively with increased tumor mass, indicating that elevated IL-6 levels enhance tumor growth and/or recurrence following PDT [260]. Here, IL6 is linked to cholangiocarcinoma.